A pharmacogenetic ‐guided treatment improves depression, anxiety outcomes

A randomized trial has found that patients whose medication treatment for depression or anxiety was guided by a pharmacogenetic test showed higher response and remission rates than patients whose treatment was guided by usual‐care standards. The study offers evidence of the applicability of the pharmacogenetic test, in that physicians in the study's first two weeks made at least one medication change in 81% of the group for whom pharmacogenetic test results were available for review. The study's findings were published online Sept. 23 in the Journal of Psychiatric Research.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Genetic Testing Source Type: research